Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S 38093 plus donepezil in moderate Alzheimer's disease
2011-005862-40Phase 2Completed
- Sponsor
- Servier
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of S-38093 in Alzheimer's disease (AD) (4 arms), sponsored by Servier. Primary endpoint: ADAS-Cog 11. Started Jun 2012; status: completed.
02
Drugs
S-38093
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2011-005862-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005862-40.